Saihe Biotechnology

Healthcare SpecialistsAngelHangzhou, China

Latest round

Angel

Last raised

Mar 2026

Total raised

Undisclosed

Investors

2

About Saihe Biotechnology

, Saihe Biotechnology, is a radiopharmaceutical development company. The company's founder, Dr.D.S. in Biomedical Engineering from Duke University and is currently a researcher at the Wenzhou Research Institute of the Chinese Academy of Sciences. The company’s main business is the research and development of innovative drugs in the field of radioactive drugs and the R&D of radionuclide coupling platform technology. The company’s self-developed product is a novel targeted delivery platform for the coupling of halogen diagnostic and therapeutic radioisotopes. Its products are used in the field of cancer diagnosis and treatment. The company generates revenue by providing research and development services related to radiopharmaceuticals and by selling anti-cancer drugs.

Who invested in Saihe Biotechnology

2 investors across 2 rounds

See all investors in Saihe Biotechnology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Mar 6, 2026

    Amount

    Undisclosed

    Investors

    Locked

  2. Angel

    Nov 21, 2024

    Amount

    Undisclosed

    Investors

    Locked

Questions about Saihe Biotechnology

Who invested in Saihe Biotechnology?

Saihe Biotechnology has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Saihe Biotechnology raised?

Saihe Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Saihe Biotechnology last raise money?

Saihe Biotechnology's most recent round on record is a Angel, in Mar 2026.

What does Saihe Biotechnology do?

, Saihe Biotechnology, is a radiopharmaceutical development company.

Where is Saihe Biotechnology headquartered?

Saihe Biotechnology is headquartered in Hangzhou, China.

Which VCs invest in companies like Saihe Biotechnology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare specialists companies at Saihe Biotechnology's stage. Their profiles are linked below.

Raising like Saihe Biotechnology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.